310 related articles for article (PubMed ID: 12629101)
1. The male contraceptive regimen of testosterone and levonorgestrel significantly increases lean mass in healthy young men in 4 weeks, but attenuates a decrease in fat mass induced by testosterone alone.
Herbst KL; Anawalt BD; Amory JK; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2003 Mar; 88(3):1167-73. PubMed ID: 12629101
[TBL] [Abstract][Full Text] [Related]
2. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: a promising male contraceptive approach.
Bebb RA; Anawalt BD; Christensen RB; Paulsen CA; Bremner WJ; Matsumoto AM
J Clin Endocrinol Metab; 1996 Feb; 81(2):757-62. PubMed ID: 8636300
[TBL] [Abstract][Full Text] [Related]
3. Levonorgestrel implants (Norplant II) for male contraception clinical trials: combination with transdermal and injectable testosterone.
Gonzalo IT; Swerdloff RS; Nelson AL; Clevenger B; Garcia R; Berman N; Wang C
J Clin Endocrinol Metab; 2002 Aug; 87(8):3562-72. PubMed ID: 12161475
[TBL] [Abstract][Full Text] [Related]
4. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
Anawalt BD; Bebb RA; Bremner WJ; Matsumoto AM
J Androl; 1999; 20(3):407-14. PubMed ID: 10386821
[TBL] [Abstract][Full Text] [Related]
5. Intramuscular testosterone enanthate plus very low dosage oral levonorgestrel suppresses spermatogenesis without causing weight gain in normal young men: a randomized clinical trial.
Anawalt BD; Amory JK; Herbst KL; Coviello AD; Page ST; Bremner WJ; Matsumoto AM
J Androl; 2005; 26(3):405-13. PubMed ID: 15867009
[TBL] [Abstract][Full Text] [Related]
6. Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist.
Matthiesson KL; Amory JK; Berger R; Ugoni A; McLachlan RI; Bremner WJ
J Clin Endocrinol Metab; 2005 Jan; 90(1):91-7. PubMed ID: 15509637
[TBL] [Abstract][Full Text] [Related]
7. Cognitive effects of short-term manipulation of serum sex steroids in healthy young men.
Cherrier MM; Anawalt BD; Herbst KL; Amory JK; Craft S; Matsumoto AM; Bremner WJ
J Clin Endocrinol Metab; 2002 Jul; 87(7):3090-6. PubMed ID: 12107206
[TBL] [Abstract][Full Text] [Related]
8. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
9. Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency virus-infected men with low testosterone levels.
Bhasin S; Storer TW; Asbel-Sethi N; Kilbourne A; Hays R; Sinha-Hikim I; Shen R; Arver S; Beall G
J Clin Endocrinol Metab; 1998 Sep; 83(9):3155-62. PubMed ID: 9745419
[TBL] [Abstract][Full Text] [Related]
10. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T.
Page ST; Amory JK; Bowman FD; Anawalt BD; Matsumoto AM; Bremner WJ; Tenover JL
J Clin Endocrinol Metab; 2005 Mar; 90(3):1502-10. PubMed ID: 15572415
[TBL] [Abstract][Full Text] [Related]
11. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
Young NR; Baker HW; Liu G; Seeman E
J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
[TBL] [Abstract][Full Text] [Related]
12. Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.
Handelsman DJ; Conway AJ; Howe CJ; Turner L; Mackey MA
J Clin Endocrinol Metab; 1996 Nov; 81(11):4113-21. PubMed ID: 8923869
[TBL] [Abstract][Full Text] [Related]
13. Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity.
Bhasin S; Parker RA; Sattler F; Haubrich R; Alston B; Umbleja T; Shikuma CM;
J Clin Endocrinol Metab; 2007 Mar; 92(3):1049-57. PubMed ID: 17164307
[TBL] [Abstract][Full Text] [Related]
14. Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.
McLachlan RI; Robertson DM; Pruysers E; Ugoni A; Matsumoto AM; Anawalt BD; Bremner WJ; Meriggiola C
J Clin Endocrinol Metab; 2004 Jan; 89(1):142-9. PubMed ID: 14715841
[TBL] [Abstract][Full Text] [Related]
15. Body weight and composition in users of levonorgestrel-releasing intrauterine system.
Dal'Ava N; Bahamondes L; Bahamondes MV; de Oliveira Santos A; Monteiro I
Contraception; 2012 Oct; 86(4):350-3. PubMed ID: 22445431
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel implants enhanced the suppression of spermatogenesis by testosterone implants: comparison between Chinese and non-Chinese men.
Wang C; Wang XH; Nelson AL; Lee KK; Cui YG; Tong JS; Berman N; Lumbreras L; Leung A; Hull L; Desai S; Swerdloff RS
J Clin Endocrinol Metab; 2006 Feb; 91(2):460-70. PubMed ID: 16278260
[TBL] [Abstract][Full Text] [Related]
17. Impact of various progestins with or without transdermal testosterone on gonadotropin levels for non-invasive hormonal male contraception: a randomized clinical trial.
Zitzmann M; Rohayem J; Raidt J; Kliesch S; Kumar N; Sitruk-Ware R; Nieschlag E
Andrology; 2017 May; 5(3):516-526. PubMed ID: 28189123
[TBL] [Abstract][Full Text] [Related]
18. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations.
Wallace EM; Gow SM; Wu FC
J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955
[TBL] [Abstract][Full Text] [Related]
19. Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men.
Allan CA; Strauss BJ; Burger HG; Forbes EA; McLachlan RI
J Clin Endocrinol Metab; 2008 Jan; 93(1):139-46. PubMed ID: 17940111
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
